OrbusNeich Medical Group Holdings Ltd
06929
Company Profile
Business description
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. Its segment include: Asia Pacific region, except Japan and the PRC (APAC), Europe, Middle East & Africa (EMEA), Japan, The PRC, and United States, of which maximum revenue is derived from APAC.
Contact
3rd Floor, Building 20E
Units 303 and 305
Hong Kong Science Park
Shatin New Town
Hong Kong
HKGT: +852 28022288
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
1,432
Stocks News & Analysis
stocks
BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs
We plan to raise our fair value estimate of BlackRock stock.
stocks
Our view of ANZ’s strategic plan
Trying to please customers and shareholders with a simpler and leaner bank.
stocks
Perplexing buyback from overvalued ASX share
Earnings continue to grow but investor expectations are too high.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,299.00 | 21.90 | 0.24% |
| CAC 40 | 8,110.14 | 190.52 | 2.41% |
| DAX 40 | 24,261.96 | 25.02 | 0.10% |
| Dow JONES (US) | 46,270.46 | 202.88 | 0.44% |
| FTSE 100 | 9,423.30 | 29.47 | -0.31% |
| HKSE | 25,910.60 | 469.25 | 1.84% |
| NASDAQ | 22,521.70 | 172.91 | -0.76% |
| Nikkei 225 | 47,672.67 | 825.35 | 1.76% |
| NZX 50 Index | 13,307.40 | 30.41 | 0.23% |
| S&P 500 | 6,644.31 | 10.41 | -0.16% |
| S&P/ASX 200 | 8,990.90 | 22.20 | 0.25% |
| SSE Composite Index | 3,912.21 | 46.98 | 1.22% |